Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Mutations in AMBRA1 aggravate β-thalassemia by impairing autophagy-mediated clearance of free α-globin

Blood blood.2023022688.

https://doi.org/10.1182/blood.2023022688

Published: 2024

Includes: Supplemental data

Journal Articles

Comparing the Efficacy and Safety of VAC (Venetoclax, Azacitidine, Chidamide) and VA Regimens As Induction Therapy for Newly Diagnosed Patients with Immunophenotypically Mature Monocytic AML

Kai-Wen Tan, Shanshan Pei, Miao Wang, Lan Dai, Hao Zhang, Chun-Yan Chen, Zhen-Qi Huang, Hai-Ping Dai, Ying Wang, Miao Miao, Yue Han, Xiaowen Tang, Huiying Qiu, Suning Chen, Aining Sun, Depei Wu, Zheng Li, Sheng-Li Xue

Blood (2024) 144 (Supplement 1): 1507.

https://doi.org/10.1182/blood-2024-204762

Published: 2024

Journal Articles

The Role of Total Body Irradiation in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma: A Multicenter Retrospective Study in China

Hongye Gao, Jiali Wang, Zhuoxin Zhang, Hao Zhang, Xin Du, Yao Liu, Dehui Zou, Xianmin Song, Erlie Jiang

Blood (2024) 144 (Supplement 1): 4867.

https://doi.org/10.1182/blood-2024-205416

Published: 2024

Journal Articles

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Fu Cheng Cheng, Song Jin, Junling Zhuang, Xin Zhou, Fan Zhou, Yuhua Li, Kaiyang Ding, Ting Niu, Wenming Chen, Baijun Fang, Li-Li Chen, Rong Fu, Hao Zhang, Jiaping Fu, Xiuju Wang, Sha Liu, Lin Li, Depei Wu

Blood (2024) 144 (Supplement 1): 6970.

https://doi.org/10.1182/blood-2024-204366

Published: 2024

Journal Articles

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Han-Yu Cao, Lu-Lu Chen, Chao-Ling Wan, Xiao-Hui Hu, Bing Wu, Li Yang, Li Wang, Yang Zhang, De-Pei Wu, Hai-Ping Dai, Hao Zhang, Shengli Xue

Blood (2023) 142 (Supplement 1): 1501.

https://doi.org/10.1182/blood-2023-179733

Published: 2023

Journal Articles

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Na Liu, Luqun WANG, Rentong Liu, Yuping Zhong, Xianqi Feng, Zhongliang Sun, Jie Li, Fanjun Meng, Junjie MA, Changyong Yuan, Hao Li, Ling Wang, Zhilong Xu, Jie Yu, Hao Zhang, Chen Chunyan

Blood (2023) 142 (Supplement 1): 6632.

https://doi.org/10.1182/blood-2023-179687

Published: 2023

Journal Articles

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Chengcheng Fu, Xin Zhou, Junling Zhuang, Fan Zhou, Yuhua Li, Wenming Chen, Rong Fu, Baijun Fang, Ting Niu, Hao Zhang, Lin Li, Depei Wu

Blood (2022) 140 (Supplement 1): 12642–12644.

https://doi.org/10.1182/blood-2022-165127

Published: 2022

Journal Articles

Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial

Blood (2022) 140 (Supplement 1): 11962–11963.

https://doi.org/10.1182/blood-2022-162507

Published: 2022

Journal Articles

MEK Inhibition in CAR-T Cells Prevents Exhaustion and Terminal Differentiation Via Downregulating C-Fos and JunB

Blood (2022) 140 (Supplement 1): 626–627.

https://doi.org/10.1182/blood-2022-158646

Published: 2022

Journal Articles

Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion

Ming Zhang, Hao Zhang, Zhihui Li, Ling Bai, Qianqian Wang, Jianfeng Li, Minghao Jiang, Qing Xue, Nuo Cheng, Weina Zhang, Dongdong Mao, Zhiming Chen, Jinyan Huang, Guoyu Meng, Zhu Chen, Sai-Juan Chen

Blood (2022) 140 (12): 1390–1407.

https://doi.org/10.1182/blood.2022016241

Published: 2022

Includes: Supplemental data

Journal Articles

Disparity Analysis and Prognostic Value of Pretreatment Whole Blood Epstein-Barr Virus DNA Load and EBER Status in Lymphomas: A Retrospective Multicenter Study in Huaihai Lymphoma Working Group

Ziyuan Shen, Lingling Hu, Jianlin Qiao, Linyan Xu, Kailin Xu, Hao Zhang, Wei Sang

Blood (2021) 138 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2021-149970

Published: 2021

Journal Articles

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Xinyi Teng, BS, Hao Zhang, MD, Zuyu Liang, MD, Mi Shao, MD, Xiujian Wang, MD, Lijuan Ding, MD, Jiazhen Cui, msc, Yongxian Hu, MD, He Huang, MD PhD

Blood (2019) 134 (Supplement_1): 5609.

https://doi.org/10.1182/blood-2019-131680

Published: 2019

Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Blood (2018) 132 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2018-99-115780

Published: 2018

Journal Articles

Warfarin Inhibits Vitamin K Epoxide Reductase By Specifically Blocking at a Conformational and Redox State

Guomin Shen, Hao Zhang, Weidong Cui, Evan Sadler, Michael Gross, Weikai Li, PhD

Blood (2014) 124 (21): 4214.

https://doi.org/10.1182/blood.V124.21.4214.4214

Published: 2014

Journal Articles

Single Cell Analysis Of JAK2 V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation

Jonathan M. Gerber, MD, Donna M. Williams, PhD, Ophelia Rogers, Sarah Morse, Hao Zhang, Michael A McDevitt, MD, PhD, Richard J. Jones, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2013) 122 (21): 1609.

https://doi.org/10.1182/blood.V122.21.1609.1609

Published: 2013

Journal Articles

The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor

Shaun-Paul Cordoba, Kaushik Choudhuri, Hao Zhang, Marcus Bridge, Alp Bugra Basat, Michael L. Dustin, P. Anton van der Merwe

Blood (2013) 121 (21): 4295–4302.

https://doi.org/10.1182/blood-2012-07-442251

Published: 2013

Includes: Supplemental data

Journal Articles

A clinically relevant population of leukemic CD34 + CD38 − cells in acute myeloid leukemia

Jonathan M. Gerber, B. Douglas Smith, Brownhilda Ngwang, Hao Zhang, Milada S. Vala, Laura Morsberger, Steven Galkin, Michael I. Collector, Brandy Perkins, Mark J. Levis, Constance A. Griffin, Saul J. Sharkis, Michael J. Borowitz, Judith E. Karp, Richard J. Jones

Blood (2012) 119 (15): 3571–3577.

https://doi.org/10.1182/blood-2011-06-364182

Published: 2012

Journal Articles

Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis

Hongfeng Yuan, Zhiqiang Wang, Ling Li, Hao Zhang, Hardik Modi, David Horne, Ravi Bhatia, WenYong Chen

Blood (2012) 119 (8): 1904–1914.

https://doi.org/10.1182/blood-2011-06-361691

Published: 2012

Includes: Supplemental data

Journal Articles

The Leukemic Stem Cell in Polycythemia Vera and Primary Myelofibrosis Is Distinct From the Initiating JAK2 V617F-Positive Hematopoiertic Stem Cell

Jonathan M. Gerber, MD, Brownhilda Ngwang, Hao Zhang, Donna M. Williams, PhD, Ophelia Rogers, Richard J. Jones, Alison R. Moliterno, MD, Jerry L. Spivak, MD

Blood (2011) 118 (21): 613.

https://doi.org/10.1182/blood.V118.21.613.613

Published: 2011

Journal Articles

The Clinical Relevance of Acute Myeloid Leukemia Stem Cells

Jonathan M. Gerber, MD, B. Douglas Smith, MD, Brownhilda Ngwang, Hao Zhang, Milada Vala, Laura Morsberger, Steven Galkin, Michael Collector, Brandy Perkins, Mark J. Levis, MD, PhD, Constance Griffin, M.D., Saul J. Sharkis, PhD, Michael J. Borowitz, MD, PhD, Judith E. Karp, MD, Richard J. Jones, MD

Blood (2011) 118 (21): 240.

https://doi.org/10.1182/blood.V118.21.240.240

Published: 2011

NARROW

Mutations in AMBRA1 aggravate β-thalassemia by impairing autophagy-mediated clearance of free α-globin

Comparing the Efficacy and Safety of VAC (Venetoclax, Azacitidine, Chidamide) and VA Regimens As Induction Therapy for Newly Diagnosed Patients with Immunophenotypically Mature Monocytic AML

The Role of Total Body Irradiation in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma: A Multicenter Retrospective Study in China

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial

MEK Inhibition in CAR-T Cells Prevents Exhaustion and Terminal Differentiation Via Downregulating C-Fos and JunB

Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion

Disparity Analysis and Prognostic Value of Pretreatment Whole Blood Epstein-Barr Virus DNA Load and EBER Status in Lymphomas: A Retrospective Multicenter Study in Huaihai Lymphoma Working Group

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Warfarin Inhibits Vitamin K Epoxide Reductase By Specifically Blocking at a Conformational and Redox State

Single Cell Analysis Of JAK2 V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation

The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor

A clinically relevant population of leukemic CD34 + CD38 − cells in acute myeloid leukemia

Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis

The Leukemic Stem Cell in Polycythemia Vera and Primary Myelofibrosis Is Distinct From the Initiating JAK2 V617F-Positive Hematopoiertic Stem Cell

The Clinical Relevance of Acute Myeloid Leukemia Stem Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only